# SLC35F1

## Overview
SLC35F1 is a gene that encodes the protein solute carrier family 35 member F1, which is part of the nucleotide sugar transporter family. This protein is primarily involved in the trafficking and localization of nucleotide sugars within cells, distinguishing itself from other family members by its predominant localization in recycling endosomes and the plasma membrane rather than the endoplasmic reticulum or Golgi apparatus (Van2024Residence). The protein contains specific tyrosine-based motifs that are crucial for its proper trafficking, allowing it to cycle between the cell surface and recycling endosomes, thus playing a unique role in cellular processes related to endosomal trafficking and recycling (Van2024Residence). SLC35F1 is mainly expressed in the brain and has been implicated in various neurological disorders and cancer-related conditions, highlighting its potential significance in disease pathogenesis and as a therapeutic target (Aryaee2023Parkinson’s; Lavoro2023In).

## Function
SLC35F1 is a member of the nucleotide sugar transporter family, primarily involved in the trafficking and localization of nucleotide sugars within cells. Unlike most nucleotide sugar transporters that are active in the endoplasmic reticulum or Golgi apparatus, SLC35F1 is predominantly localized in recycling endosomes and the plasma membrane, suggesting a unique role in cellular processes (Van2024Residence). The protein contains two critical tyrosine-based motifs in its C-terminal region, Y367KQF and Y392TSL, which are essential for its proper trafficking and localization. These motifs help direct SLC35F1 away from lysosomal sorting and into recycling pathways, allowing it to cycle between the cell surface and recycling endosomes (Van2024Residence).

SLC35F1 is mainly expressed in the brain, where it is involved in recycling endosomes of neuronal cells, potentially influencing cellular processes related to endosomal trafficking and recycling (Farenholtz2019Expression; Van2024Residence). The protein's presence in endosomes and lysosomes is unusual and suggests it might play a role in storing nucleotide sugars within these organelles, which could be released via exocytosis, contributing to extracellular glycosylation processes (Van2024Residence).

## Clinical Significance
The SLC35F1 gene has been implicated in several neurological and cancer-related conditions due to its altered expression levels and potential genetic associations. In the context of neurological disorders, SLC35F1 has been identified as a hub gene significantly associated with both Parkinson's Disease (PD) and epilepsy. Studies have shown a significant downregulation of SLC35F1 in patients with these conditions, suggesting its involvement in shared neurodegenerative pathways and synaptic processes (Aryaee2023Parkinson’s).

In cancer research, SLC35F1 has been linked to mucinous colorectal cancer through genome-wide association studies, although the specific role of SLC35F1 in this cancer type remains unclear (Penney2018Associations). Additionally, SLC35F1 expression is upregulated in lower-grade glioma and glioblastoma multiforme, indicating a potential role in tumor biology and suggesting that its expression may be linked to cancer progression and response to treatment (Lavoro2023In).

Despite these associations, the precise mechanisms by which SLC35F1 contributes to these diseases are not fully understood, and further research is needed to elucidate its role in disease pathogenesis and potential as a therapeutic target.

## Interactions
SLC35F1 is involved in interactions related to vesicular transport processes within cells. It co-localizes with Rab11, a protein associated with the exocytosis of recycling vesicles, indicating a potential role in Rab11-dependent processes (Farenholtz2019Expression; Van2024Residence). This co-localization suggests that SLC35F1 may participate in the recycling endosome pathway, as it is enriched in Rab11/TfR-positive endosomes and the plasma membrane, cycling between the cell surface and recycling endosomes (Van2024Residence). 

The protein's localization is influenced by specific motifs in its C-terminal region, which are crucial for its presence in recycling endosomes. Mutations in these motifs can alter its distribution, affecting its presence on the plasma membrane (Van2024Residence). The Y392 TSL motif is particularly important for diverting SLC35F1 from lysosomal sorting, favoring its recycling to the plasma membrane (Van2024Residence). 

While SLC35F1's interactions with other proteins are not extensively detailed, its co-localization with Rab11 and involvement in recycling pathways suggest it plays a role in cellular trafficking processes, potentially interacting with other proteins associated with these pathways (Farenholtz2019Expression; Van2024Residence).


## References


1. (Aryaee2023Parkinson’s) Parkinson’s Disease and Epilepsy: A bioinformatics analysis. This article has 0 citations.

[2. (Penney2018Associations) Michelle E. Penney, Patrick S. Parfrey, Sevtap Savas, and Yildiz E. Yilmaz. Associations of single nucleotide polymorphisms with mucinous colorectal cancer: genome-wide common variant and gene-based rare variant analyses. Biomarker Research, June 2018. URL: http://dx.doi.org/10.1186/s40364-018-0133-z, doi:10.1186/s40364-018-0133-z. This article has 6 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s40364-018-0133-z)

[3. (Lavoro2023In) Alessandro Lavoro, Luca Falzone, Barbara Tomasello, Giuseppe Nicolò Conti, Massimo Libra, and Saverio Candido. In silico analysis of the solute carrier (slc) family in cancer indicates a link among dna methylation, metabolic adaptation, drug response, and immune reactivity. Frontiers in Pharmacology, June 2023. URL: http://dx.doi.org/10.3389/fphar.2023.1191262, doi:10.3389/fphar.2023.1191262. This article has 8 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fphar.2023.1191262)

[4. (Van2024Residence) François Van den Bossche, Virginie Tevel, Florentine Gilis, Jean-François Gaussin, Marielle Boonen, and Michel Jadot. Residence of the nucleotide sugar transporter family members slc35f1 and slc35f6 in the endosomal/lysosomal pathway. International Journal of Molecular Sciences, 25(12):6718, June 2024. URL: http://dx.doi.org/10.3390/ijms25126718, doi:10.3390/ijms25126718. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms25126718)

[5. (Farenholtz2019Expression) Jacob Farenholtz, Nadine Artelt, Antje Blumenthal, Karlhans Endlich, Heyo K. Kroemer, Nicole Endlich, and Oliver von Bohlen und Halbach. Expression of slc35f1 in the murine brain. Cell and Tissue Research, 377(2):167–176, March 2019. URL: http://dx.doi.org/10.1007/s00441-019-03008-8, doi:10.1007/s00441-019-03008-8. This article has 5 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s00441-019-03008-8)